Skip to main content Accessibility help
×
Home

Evaluation of serum ischaemia-modified albumin levels in patients with Bell's palsy

  • A E Göker (a1), M H Alagöz (a2), G Güntaş (a3), A Baskadem Yilmazer (a1), G Berkiten (a1), B Tutar (a1), ME Ekincioglu (a1), M F Akgun (a1), Y Uyar (a1) and E Ozdemir (a1)...

Abstract

Objective

This prospective study aimed to evaluate the relationship between serum ischaemia-modified albumin levels and Bell's palsy severity.

Methods

The study included 30 patients diagnosed with Bell's palsy and 30 healthy individuals. The patients were separated into three disease severity groups (grades 2, 3 and 4) according to House–Brackmann classification. Blood samples were collected from all participants and the results compared between groups.

Results

Significant differences in serum ischaemia-modified albumin were found between the study and control groups (p < 0.001); values were significantly higher in the study group than in the control group.

Conclusion

The significantly higher levels of serum ischaemia-modified albumin in the study group suggest that Bell's palsy pathogenesis is associated with oxidative stress.

Copyright

Corresponding author

Author for correspondence: Dr Ayşe Enise Göker, Department of Otorhinolaryngology – Head and Neck Surgery, University of Health Sciences, Okmeydani Training and Research Hospital, Istanbul, Turkey E-mail: ayseenise@hotmail.com

Footnotes

Hide All

Dr A E Göker takes responsibility for the integrity of the content of the paper

Footnotes

References

Hide All
1Peitersen, E. Bell's palsy: the spontaneous course of 2,500 peripheral facial nerve palsies of different etiologies. Acta Otolaryngol Suppl 2002;549:430
2Baugh, RF, Basura, GJ, Ishii, LE, Schwartz, SR, Drumheller, CM, Burkholder, R et al. Clinical practice guideline: Bell's palsy. Otolaryngol Head Neck Surg 2013;149(3 suppl):S127
3Greco, A, Gallo, A, Fusconi, M, Marinelli, C, Macri, GF, de Vincentiis, M. Bell's palsy and autoimmunity. Autoimmun Rev 2012;12:323–8
4Collinson, PO, Gaze, DC, Bainbridge, K, Morris, F, Morris, B, Price, A et al. Utility of admission cardiac troponin and “Ischemia Modified Albumin” measurements for rapid evaluation and rule out of suspected acute myocardial infarction in the emergency department. Emerg Med J 2006;23:256–61
5Cai, Z, Li, H, Wang, X, Niu, X, Ni, P, Zhang, W et al. Prognostic factors of Bell's palsy and Ramsay Hunt syndrome. Medicine (Baltimore) 2017;96:e5898
6Erdem, SS, Yerlikaya, FH, Çiçekler, H, Gül, M. Association between ischemia modified albumin, homocysteine, vitamin B(12) and folic acid in patients with severe sepsis. Clin Chem Lab Med 2012;50:1417–21
7Ellidag, HY, Eren, E, Aydin, O, Akgol, E, Yalcinkaya, S, Sezer, C et al. Ischemia modified albumin levels and oxidative stress in patients with bladder cancer. Asian Pac J Cancer Prev 2013;14:2759–63
8Güldoğan, CE, Kılıç, , Balamir, İ, Tez, M, Turhan, T. Correlation between ischemia-modified albumin and Ranson score in acute pancreatitis. Ulus Travma Acil Cerrahi Derg 2017;23:472–6
9Seshadri Reddy, V, Munikumar, M, Duggina, P, Varma, N. A diagnostic test accuracy meta-analysis of maternal serum ischemia-modified albumin for detection of preeclampsia. J Matern Fetal Neonatal Med 2019;32:2173–81
10Terzi, S, Dursun, E, Yılmaz, A, Özergin Coşkun, Z, Özgür, A, Çeliker, M et al. Oxidative stress and antioxidant status in patients with Bell's palsy. J Med Biochem 2017;36:1822
11Murakami, S, Mizobuchi, M, Nakashiro, Y, Doi, T, Hato, N, Yanagihara, N. Bell palsy and herpes simplex virus: identification of viral DNA in endoneurial fluid and muscle. Ann Intern Med 1996;124(1 Pt 1):2730
12Glass, GE, Tzafetta, K. Bell's palsy: a summary of current evidence and referral algorithm. Fam Pract 2014;31:631–42
13Iritani, H, Nishimura, Y, Minatogawa, T. Neurophysiology of ischemic facial nerve paralysis in an animal model. Acta Otolaryngol 1991;111:934–42
14Can, Ü, Yosunkaya, Ş. A new marker in ischemia: ischemia-modified albumin [in Turkish]. Kosuyolu Heart J 2017;20:148–52
15Gaze, DC. Ischemia modified albumin: a novel biomarker for the detection of cardiac ischemia. Drug Metab Pharmacokinet 2009;24:333–41
16Mastella, AK, Moresco, RN, da Silva, DB, Becker, AM, Duarte Marta, MMF, Giovelli, LL et al. Evaluation of ischemia-modified albumin in myocardial infarction and prostatic diseases. Biomed Pharmacother 2009;63:762–6
17Fidan, E, Mentese, A, Kavgaci, H, Orem, A, Fidan, S, Uzun, A et al. Increased ischemia-modified albumin levels in patients with gastric cancer. Neoplasma 2012;59:393–7
18Stachowicz-Stencel, T, Synakiewicz, A, Owczarzak, A, Sliwinska, A, Aleksandrowicz-Wrona, E, Lysiak-Szydowska, W et al. Ischemia-modified albumin as a biochemical marker in children with neuroblastoma and soft tissue sarcomas. J Clin Lab Anal 2011;25:255–8
19Babademez, MA, Gul, F, Kale, H, Muderris, T, Bayazit, Y, Ergin, M et al. Thiol/disulphide homeostasis in Bell's palsy as a novel pathogenetic marker. Clin Otolaryngol 2017;42:239–44
20Kang, TS, Vrabec, JT, Giddings, N, Terris, DJ. Facial nerve grading systems (1985–2002): beyond the House-Brackmann scale. Otol Neurotol 2002;23:767–71

Keywords

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed